Mountfort Katrina, Khashaba Ahmed, Garbo Roberto, Tigen Kurstat, Moellmann Helge, Morice Marie-Claude
Medical Writer, Radcliffe Cardiology.
Ain Shams University and the Al Dorrah Heart Care Hospital Cairo, Egypt.
Interv Cardiol. 2015 Sep;10(3):162-166. doi: 10.15420/ICR.2015.10.03.162.
The use of drug-eluting stents (DES) has improved clinical outcomes in percutaneous coronary intervention procedures, but many challenges remain. In two symposia at EuroPCR 2015, the factors necessary to ensure successful chronic total occlusion (CTO) intervention were presented. Good preparation, sufficient operator experience and the correct approach are key to the success of CTO interventions. A live case demonstrated the challenges of these complex cases. Stent choice in CTO interventions is crucial; second-generation DES are associated with lower rates of restenosis and re-occlusion compared with first-generation DES. The Coracto™ DES features unique structural properties and rapidly absorbable polymer, resulting in excellent conformability, efficacy and safety.
药物洗脱支架（DES）的使用改善了经皮冠状动脉介入治疗的临床结果，但仍存在许多挑战。在2015年欧洲心脏病介入治疗大会（EuroPCR）的两场专题研讨会上，介绍了确保成功进行慢性完全闭塞（CTO）介入治疗所需的因素。充分的准备、丰富的术者经验以及正确的方法是CTO介入治疗成功的关键。一个实际病例展示了这些复杂病例所面临的挑战。CTO介入治疗中支架的选择至关重要；与第一代DES相比，第二代DES的再狭窄和再闭塞发生率较低。Coracto™ DES具有独特的结构特性和可快速吸收的聚合物，具有出色的顺应性、有效性和安全性。
